Quick Takeaways
- Daniel B. Soland has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $961,891.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Daniel B. Soland and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | Director | $927,091 | 29 May 2025 | ||
| DBVT, DBVTF | DBV Technologies S.A. | Director | $34,800 | 01 Aug 2023 | ||
| IDRA | IDERA PHARMACEUTICALS, INC. | Chief Operating Officer | 06 Jul 2022 | |||
| KALV | KalVista Pharmaceuticals, Inc. | Director | 30 Sep 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|